Financials in USD. Standardized financial statements.
A compact view of how Trinity Biotech plc turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $43.92M | $61.55M | $56.83M | $62.52M | $81.15M | $101.98M | $90.44M | $97.03M | $99.14M | $99.61M |
| Revenue Growth? | -28.6% | +8.3% | -9.1% | -23.0% | -20.4% | +12.8% | -6.8% | -2.1% | -0.5% | 0.0% |
| Cost of Revenue? | $28.37M | $40.11M | $37.38M | $52.73M | $54.89M | $53.40M | $52.31M | $55.59M | $57.25M | $56.52M |
| Gross Profit? | $15.55M | $21.44M | $19.45M | $22.05M | $33.45M | $48.58M | $38.12M | $41.45M | $41.89M | $43.09M |
| Gross Margin? | +35.4% | +34.8% | +34.2% | +35.3% | +41.2% | +47.6% | +42.2% | +42.7% | +42.3% | +43.3% |
| Operating Expenses? | $26.51M | $42.61M | $46.49M | $32.96M | $29.52M | $48.50M | $32.82M | $34.77M | $36.41M | $35.60M |
| Operating Income? | -$10.96M | -$21.16M | -$27.05M | -$15.27M | $3.94M | $82,000 | $872,000 | $3.30M | $5.48M | $7.49M |
| EBITDA? | -$8.26M | -$16.91M | -$24.10M | -$16.71M | $10.59M | $3.19M | -$19.52M | -$13.98M | -$29.27M | -$30.92M |
| Income Before Tax | -$37.29M | -$30.73M | -$36.93M | -$43.78M | -$1.92M | -$6.63M | $821,000 | $3.03M | $1.60M | $5.19M |
| Income Tax Expense | $199,615 | $486,000 | -$59,000 | -$194,000 | -$74,000 | -$620,000 | $4.89M | $637,000 | -$697,000 | $41,000 |
| Net Income? | -$37.49M | -$31.79M | -$24.02M | -$41.00M | $875,000 | -$6.39M | -$4.07M | $2.39M | -$40.27M | -$100.63M |
| EPS? | $-2.00 | $-1.77 | $-3.20 | $-6.00 | $0.21 | $-1.54 | $-0.97 | $0.57 | $-9.31 | $-21.91 |
| Diluted EPS? | $-2.00 | $-1.77 | $-3.20 | $-5.20 | $0.16 | $-1.54 | $-0.80 | $0.46 | $-7.49 | $-17.78 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality